Cargando…
Clinical significance of p16(INK4A) and p14(ARF) promoter methylation in renal cell carcinoma: a meta-analysis
The inactivation of p16(INK4A) and p14(ARF) via promoter methylation has been investigated in various cancers. However, the clinical effects of p16(INK4A) and p14(ARF) promoter methylation on renal cell carcinoma (RCC) remain to be clarified. The pooled data were calculated and summarized. Finally,...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610010/ https://www.ncbi.nlm.nih.gov/pubmed/28969078 http://dx.doi.org/10.18632/oncotarget.18826 |